v3 Template
E

Epigenic Therapeutics

Biotechnology
Founded
--
Employees
--
Total Funding
$92.0M
Funding Rounds
2
Last Funding
2025-09-07

About Epigenic Therapeutics

Epigenic Therapeutics is dedicated to pioneering epigenetic medicine, focusing on developing next-generation gene modulation therapies using epigenetic genome regulation to treat a variety of human diseases.

Products & Services

Epigenetic Modulator Platform:A technology platform that uses nuclease-inactivated dead Cas protein and epi-enzymes to precisely control gene expression for disease treatment without DNA cutting, nicking, or altering. It offers high efficiency, durability, non-viral delivery, favorable safety, and cost-effectiveness.
EPI-003:A first-in-class epigenetic inactivator in clinical development for the treatment of Chronic Hepatitis B.

Specialties

Epigenetic Medicine Gene Modulation Therapy Epigenetic Genome Regulation Chronic Hepatitis B Treatment CAR-T Function Enhancement

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B 		A: 60000000
MR: -
FA: $60 million
FAN: 60000000 		D: 2025-09-07
FD: 2025-09-07 		4 investors
2 RT: Series A
T: -
FT: Series A 		A: 32000000
MR: -
FA: 32 million
FAN: 32000000 		D: 2023-08-29
FD: 2023-08-29 		3 investors
Series B Latest
2025-09-07
$60.0M
4 investors (Pro only)
Series A 2023-08-29
$32.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Epigenic Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro